IP Library › Granted Patent US 12,377,131
Granted Patent B2
US 12,377,131 · App. 18/179,198 · Granted Aug 5, 2025

Cytokine conjugates for the treatment of autoimmune diseases

Inventors: Carolina E. Caffaro (San Diego, CA); Marcos Milla (Carlsbad, CA); Jerod Ptacin (San Diego, CA)
Assignee: SYNTHORX, INC.
A61K38/2013A61K47/542A61K47/60A61K47/61A61K47/643A61K47/644A61K47/65A61K47/68C07K14/55C07K14/7155A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,377,131
App. No.
18/179,198
Granted
Aug 5, 2025
Kind
B2
Abstract

Disclosed herein are interleukin (IL) conjugates (e.g., IL-2 conjugates) and use in the treatment of one or more indications. Also described herein are pharmaceutical compositions and kits comprising one or more of the interleukin conjugates (e.g., IL-2 conjugates).

Claims (25)

1. A method of expanding CD4+ regulatory T (Treg) cells in a subject in need thereof, comprising administering to a subject having an autoimmune disease or disorder a therapeutically effective amount of a modified interleukin 2 (IL-2) polypeptide comprising an IL-2 polypeptide comprising at least one unnatural amino acid covalently attached to a conjugating moiety,

wherein the position of the at least one unnatural amino acid is K9, H16, L19, V91, E100, or T123, wherein the residue positions correspond to positions 9, 16, 19, 91, 100, and 123 as set forth in SEQ ID NO: 1; and

wherein the IL-2 polypeptide comprises at least 90% sequence identity to SEQ ID NO: 1.

2. The method of claim 1 , wherein the autoimmune disease or disorder comprises alopecia areata, autoimmune hemolytic anemia, autoimmune hepatitis, dermatomyositis, type 1 diabetes, juvenile idiopathic arthritis, glomerulonephritis, Graves' disease, Guillain-Barré syndrome, idiopathic thrombocytepenic purpura, myasthenia gravis, multiple sclerosis, pemphigus/pemphigoid, pernicious anemia, polyarteritis nodosa, polymyositis, primary biliary cirrhosis, psoriasis, rheumatoid arthritis, scleroderma, Sjögren's syndrome, systemic lupus erythematosus, thyroiditis, uveitis, vitiligo, or Wegener's granulomatosis.

3. The method of claim 1 , wherein the position of the at least one unnatural amino acid is H16.

4. The method of claim 1 , wherein the position of the at least one unnatural amino acid is K9 or L19.

5. The method of claim 1 , wherein the at least one unnatural amino acid is a lysine analogue or comprises an aromatic side chain.

6. The method of claim 1 , wherein the at least one unnatural amino acid comprises p-acetyl-L-phenylalanine, p-azidomethyl-L-phenylalanine (pAMF), p-iodo-L-phenylalanine, m-acetylphenylalanine, p-propargyloxyphenylalanine, p-propargyl-phenylalanine, 3-methyl-phenylalanine, fluorinated phenylalanine, isopropyl-L-phenylalanine, p-azido-L-phenylalanine, p-acyl-L-phenylalanine, p-benzoyl-L-phenylalanine, p-bromophenylalanine, p-amino-L-phenylalanine, O-allyltyrosine, O-methyl-L-tyrosine, O-4-allyl-L-tyrosine, 4-propyl-L-tyrosine, phosphonotyrosine, L-3-(2-naphthyl) alanine, 2-amino-3-((2-((3-(benzyloxy)-3-oxopropyl)amino)ethyl) selanyl) propanoic acid, or 2-amino-3-(phenylselanyl) propanoic acid.

7. The method of claim 1 , wherein the IL-2 polypeptide comprises an N-terminal deletion, wherein the N-terminal deletion comprises a deletion of the first 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 residues from the N-terminus, wherein the residue positions correspond to the positions as set forth in SEQ ID NO: 1.

8. The method of claim 1 , wherein the conjugating moiety comprises a water-soluble polymer, a lipid, a protein, or a peptide.

9. The method of claim 8 , wherein the conjugating moiety comprises a water-soluble polymer.

10. The method of claim 9 , wherein the water-soluble polymer comprises polyethylene glycol (PEG), poly (propylene glycol) (PPG), copolymers of ethylene glycol and propylene glycol, poly (oxyethylated polyol), poly (olefinic alcohol), poly (vinylpyrrolidone), poly (hydroxyalkylmethacrylamide), poly (hydroxyalkylmethacrylate), poly (saccharides), poly (a-hydroxy acid), poly (vinyl alcohol), polyphosphazene, polyoxazolines (POZ), poly (N-acryloylmorpholine), or a combination thereof.

11. The method of claim 10 , wherein the water-soluble polymer comprises PEG.

12. The method of claim 11 , wherein the PEG has a molecular weight from about 10 kDa to about 85 kDa.

13. The method of claim 12 , wherein the PEG has a molecular weight of about 20 kDa, about 25 kDa, about 30 kDa, about 35 kDa, about 40 kDa, about 45 kDa, about 50 kDa, about 55 kDa, or about 60 kDa.

14. The method of claim 13 , wherein the PEG has a molecular weight of about 50 kDa.

15. The method of claim 1 , wherein the at least one unnatural amino acid is covalently attached to the conjugating moiety through a linker, wherein the linker comprises a homobifunctional linker, a heterobifunctional linker, a cleavable or a non-cleavable dipeptide linker, a spacer, or a combination thereof.

16. The method of claim 1 , wherein the IL-2 polypeptide comprises at least about 95% sequence identity to SEQ ID NO: 1.

17. The method of claim 16 , wherein the IL-2 polypeptide comprises at least 97% sequence identity to SEQ ID NO: 1.

18. The method of claim 1 , wherein the modified IL-2 polypeptide is administered as a pharmaceutical composition comprising the modified IL-2 polypeptide.

19. The method of claim 1 , wherein the conjugating moiety comprises PEG, wherein the position of the at least one unnatural amino acid is H16, wherein the residue position corresponds to position 16 as set forth in SEQ ID NO: 1, and wherein the at least one unnatural amino acid is a lysine analogue.

20. The method of claim 1 , further comprising administering to the subject an additional therapeutic agent.

21. The method of claim 20 , wherein the modified IL-2 polypeptide is administered prior to the administration of the additional therapeutic agent.

22. The method of claim 20 , wherein the modified IL-2 polypeptide is administered after the administration of the additional therapeutic agent.

23. The method of claim 1 , wherein the modified IL-2 polypeptide selectively expands CD4+Treg cells in the subject.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2025
From: SYNTHORX, INC.
To: SANOFI
Reel/Frame 073718/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2023
From: PTACIN, JEROD; CAFFARO, CAROLINA E.; MILLA, MARCOS
To: SYNTHORX, INC.
Reel/Frame 063298/0036 →
Continuity (3)
Division 16634487
Provisional Application 62540781 · Aug 3, 2017
Related Publication 20230302089A1 · Sep 28, 2023
References Cited (400)
US 3687808A · Merigan, Jr. et al. · 1972 [cited by applicant]
US 4469863A · Ts'o et al. · 1984 [cited by applicant]
US 4476301A · Imbach et al. · 1984 [cited by applicant]
US 4587044A · Miller et al. · 1986 [cited by applicant]
US 4667025A · Miyoshi et al. · 1987 [cited by applicant]
US 4683195A · Mullis et al. · 1987 [cited by applicant]
US 4683202A · Mullis · 1987 [cited by applicant]
US 4762779A · Snitman · 1988 [cited by applicant]
US 4766106A · Katre et al. · 1988 [cited by applicant]
US 4789737A · Miyoshi et al. · 1988 [cited by applicant]
US 4824941A · Gordon et al. · 1989 [cited by applicant]
US 4828979A · Klevan et al. · 1989 [cited by applicant]
US 4835263A · Nguyen et al. · 1989 [cited by applicant]
US 4845205A · Dinh et al. · 1989 [cited by applicant]
US 4849513A · Smith et al. · 1989 [cited by applicant]
US 4851512A · Miyaji et al. · 1989 [cited by applicant]
US 4876335A · Yamane et al. · 1989 [cited by applicant]
US 4902502A · Nitecki et al. · 1990 [cited by applicant]
US 4904582A · Tullis · 1990 [cited by applicant]
US 4910300A · Urdea et al. · 1990 [cited by applicant]
US 4931544A · Katre et al. · 1990 [cited by applicant]
US 4948882A · Ruth · 1990 [cited by applicant]
US 4958013A · Letsinger · 1990 [cited by applicant]
US 4965188A · Mullis et al. · 1990 [cited by applicant]
US 4981957A · Lebleu et al. · 1991 [cited by applicant]
US 5015733A · Smith et al. · 1991 [cited by applicant]
US 5023243A · Tullis · 1991 [cited by applicant]
US 5034506A · Summerton et al. · 1991 [cited by applicant]
US 5082830A · Brakel et al. · 1992 [cited by applicant]
US 5089261A · Nitecki et al. · 1992 [cited by applicant]
US 5093232A · Urdea et al. · 1992 [cited by applicant]
US 5109124A · Ramachandran et al. · 1992 [cited by applicant]
US 5112963A · Pieles et al. · 1992 [cited by applicant]
US 5118800A · Smith et al. · 1992 [cited by applicant]
US 5118802A · Smith et al. · 1992 [cited by applicant]
US 5130302A · Spielvogel et al. · 1992 [cited by applicant]
US 5134066A · Rogers et al. · 1992 [cited by applicant]
US 5138045A · Cook et al. · 1992 [cited by applicant]
US 5166315A · Summerton et al. · 1992 [cited by applicant]
US 5175273A · Bischofberger et al. · 1992 [cited by applicant]
US 5177196A · Meyer, Jr. et al. · 1993 [cited by applicant]
US 5185444A · Summerton et al. · 1993 [cited by applicant]
US 5188897A · Suhadolnik et al. · 1993 [cited by applicant]
US 5206344A · Katre et al. · 1993 [cited by applicant]
US 5214134A · Weis et al. · 1993 [cited by applicant]
US 5214136A · Lin et al. · 1993 [cited by applicant]
US 5216141A · Benner · 1993 [cited by applicant]
US 5218105A · Cook et al. · 1993 [cited by applicant]
US 5229109A · Grimm et al. · 1993 [cited by applicant]
US 5232841A · Hashimoto et al. · 1993 [cited by applicant]
US 5235033A · Summerton et al. · 1993 [cited by applicant]
US 5245022A · Weis et al. · 1993 [cited by applicant]
US 5254469A · Warren, III et al. · 1993 [cited by applicant]
US 5258506A · Urdea et al. · 1993 [cited by applicant]
US 5262536A · Hobbs, Jr. · 1993 [cited by applicant]
US 5264423A · Cohen et al. · 1993 [cited by applicant]
US 5264562A · Matteucci · 1993 [cited by applicant]
US 5264564A · Matteucci · 1993 [cited by applicant]
US 5268273A · Buckholz · 1993 [cited by applicant]
US 5272250A · Spielvogel et al. · 1993 [cited by applicant]
US 5276019A · Cohen et al. · 1994 [cited by applicant]
US 5278302A · Caruthers et al. · 1994 [cited by applicant]
US 5286717A · Cohen et al. · 1994 [cited by applicant]
US 5292873A · Rokita et al. · 1994 [cited by applicant]
US 5317098A · Shizuya et al. · 1994 [cited by applicant]
US 5319080A · Leumann · 1994 [cited by applicant]
US 5321131A · Agrawal et al. · 1994 [cited by applicant]
US 5359044A · Cook et al. · 1994 [cited by applicant]
US 5367066A · Urdea et al. · 1994 [cited by applicant]
US 5370995A · Hennecke et al. · 1994 [cited by applicant]
US 5371241A · Brush · 1994 [cited by applicant]
US 5389529A · Panayotatos et al. · 1995 [cited by applicant]
US 5391723A · Priest · 1995 [cited by applicant]
US 5393878A · Leumann · 1995 [cited by applicant]
US 5399676A · Froehler · 1995 [cited by applicant]
US 5405938A · Summerton et al. · 1995 [cited by applicant]
US 5405939A · Suhadolnik et al. · 1995 [cited by applicant]
US 5414077A · Lin et al. · 1995 [cited by applicant]
US 5416203A · Letsinger · 1995 [cited by applicant]
US 5432272A · Benner · 1995 [cited by applicant]
US 5434257A · Matteucci et al. · 1995 [cited by applicant]
US 5446137A · Maag et al. · 1995 [cited by applicant]
US 5451463A · Nelson et al. · 1995 [cited by applicant]
US 5453496A · Caruthers et al. · 1995 [cited by applicant]
US 5455233A · Spielvogel et al. · 1995 [cited by applicant]
US 5457187A · Gmeiner et al. · 1995 [cited by applicant]
US 5459255A · Cook et al. · 1995 [cited by applicant]
US 5466677A · Baxter et al. · 1995 [cited by applicant]
US 5466786A · Buhr et al. · 1995 [cited by applicant]
US 5470719A · Meng et al. · 1995 [cited by applicant]
US 5470967A · Huie et al. · 1995 [cited by applicant]
US 5476925A · Letsinger et al. · 1995 [cited by applicant]
US 5484908A · Froehler et al. · 1996 [cited by applicant]
US 5486603A · Buhr · 1996 [cited by applicant]
US 5489677A · Sanghvi et al. · 1996 [cited by applicant]
US 5502177A · Matteucci et al. · 1996 [cited by applicant]
US 5510475A · Agrawal et al. · 1996 [cited by applicant]
US 5512439A · Hornes et al. · 1996 [cited by applicant]
US 5512667A · Reed et al. · 1996 [cited by applicant]
US 5514785A · Ness et al. · 1996 [cited by applicant]
US 5519126A · Hecht · 1996 [cited by applicant]
US 5519134A · Acevedo et al. · 1996 [cited by applicant]
US 5525465A · Haralambidis et al. · 1996 [cited by applicant]
US 5525711A · Hawkins et al. · 1996 [cited by applicant]
US 5536821A · Agrawal et al. · 1996 [cited by applicant]
US 5539082A · Nielsen et al. · 1996 [cited by applicant]
US 5541306A · Agrawal et al. · 1996 [cited by applicant]
US 5541307A · Cook et al. · 1996 [cited by applicant]
US 5541313A · Ruth · 1996 [cited by applicant]
US 5545730A · Urdea et al. · 1996 [cited by applicant]
US 5550111A · Suhadolnik et al. · 1996 [cited by applicant]
US 5552538A · Urdea et al. · 1996 [cited by applicant]
US 5552540A · Haralambidis · 1996 [cited by applicant]
US 5561225A · Maddry et al. · 1996 [cited by applicant]
US 5563253A · Agrawal et al. · 1996 [cited by applicant]
US 5565552A · Magda et al. · 1996 [cited by applicant]
US 5567810A · Weis et al. · 1996 [cited by applicant]
US 5567811A · Misiura et al. · 1996 [cited by applicant]
US 5571799A · Tkachuk et al. · 1996 [cited by applicant]
US 5574142A · Meyer, Jr. et al. · 1996 [cited by applicant]
US 5576427A · Cook et al. · 1996 [cited by applicant]
US 5578717A · Urdea et al. · 1996 [cited by applicant]
US 5578718A · Cook et al. · 1996 [cited by applicant]
US 5580731A · Chang et al. · 1996 [cited by applicant]
US 5585481A · Arnold, Jr. et al. · 1996 [cited by applicant]
US 5587361A · Cook et al. · 1996 [cited by applicant]
US 5587371A · Sessler et al. · 1996 [cited by applicant]
US 5587469A · Cook et al. · 1996 [cited by applicant]
US 5591584A · Chang et al. · 1997 [cited by applicant]
US 5591722A · Montgomery et al. · 1997 [cited by applicant]
US 5594121A · Froehler et al. · 1997 [cited by applicant]
US 5595726A · Magda et al. · 1997 [cited by applicant]
US 5595899A · Sato et al. · 1997 [cited by applicant]
US 5596086A · Matteucci et al. · 1997 [cited by applicant]
US 5596091A · Switzer · 1997 [cited by applicant]
US 5597696A · Linn et al. · 1997 [cited by applicant]
US 5597909A · Urdea et al. · 1997 [cited by applicant]
US 5599923A · Sessler et al. · 1997 [cited by applicant]
US 5599928A · Hemmi et al. · 1997 [cited by applicant]
US 5602240A · Mesmaeker et al. · 1997 [cited by applicant]
US 5608046A · Cook et al. · 1997 [cited by applicant]
US 5610289A · Cook et al. · 1997 [cited by applicant]
US 5610300A · Altmann et al. · 1997 [cited by applicant]
US 5612199A · Western et al. · 1997 [cited by applicant]
US 5614185A · Koths et al. · 1997 [cited by applicant]
US 5614617A · Cook et al. · 1997 [cited by applicant]
US 5618704A · Sanghvi et al. · 1997 [cited by applicant]
US 5623070A · Cook et al. · 1997 [cited by applicant]
US 5625050A · Beaton et al. · 1997 [cited by applicant]
US 5627053A · Usman et al. · 1997 [cited by applicant]
US 5633360A · Bischofberger et al. · 1997 [cited by applicant]
US 5639873A · Barascut et al. · 1997 [cited by applicant]
US 5643564A · Hamaguchi et al. · 1997 [cited by applicant]
US 5645985A · Froehler et al. · 1997 [cited by applicant]
US 5646265A · McGee · 1997 [cited by applicant]
US 5648247A · Picataggio et al. · 1997 [cited by applicant]
US 5656493A · Mullis et al. · 1997 [cited by applicant]
US 5658873A · Bertsch-Frank et al. · 1997 [cited by applicant]
US 5663312A · Chaturvedula · 1997 [cited by applicant]
US 5670633A · Cook et al. · 1997 [cited by applicant]
US 5677437A · Teng et al. · 1997 [cited by applicant]
US 5677439A · Weis et al. · 1997 [cited by applicant]
US 5681941A · Cook et al. · 1997 [cited by applicant]
US 5688941A · Cook et al. · 1997 [cited by applicant]
US 5700920A · Altmann et al. · 1997 [cited by applicant]
US 5712114A · Mankovich et al. · 1998 [cited by applicant]
US 5714331A · Buchardt et al. · 1998 [cited by applicant]
US 5719262A · Buchardt et al. · 1998 [cited by applicant]
US 5747646A · Hakimi et al. · 1998 [cited by applicant]
US 5750692A · Cook et al. · 1998 [cited by applicant]
US 5763588A · Matteucci et al. · 1998 [cited by applicant]
US 5830653A · Froehler et al. · 1998 [cited by applicant]
US 5834594A · Hakimi et al. · 1998 [cited by applicant]
US 5846818A · Robinson et al. · 1998 [cited by applicant]
US 5888732A · Hartley et al. · 1999 [cited by applicant]
US 5932474A · Tsien et al. · 1999 [cited by applicant]
US 6005096A · Matteucci et al. · 1999 [cited by applicant]
US 6008378A · Tsien et al. · 1999 [cited by applicant]
US 6010871A · Takahara et al. · 2000 [cited by applicant]
US 6013526A · Takahara et al. · 2000 [cited by applicant]
US 6054271A · Tsien et al. · 2000 [cited by applicant]
US 6124090A · Rose et al. · 2000 [cited by applicant]
US 6143557A · Hartley et al. · 2000 [cited by applicant]
US 6171861B1 · Hartley et al. · 2001 [cited by applicant]
US 6261797B1 · Sorge et al. · 2001 [cited by applicant]
US 6268490B1 · Imanishi et al. · 2001 [cited by applicant]
US 6270969B1 · Hartley et al. · 2001 [cited by applicant]
US 6277608B1 · Hartley et al. · 2001 [cited by applicant]
US 6288302B1 · Yu et al. · 2001 [cited by applicant]
US 6294323B1 · Ullman et al. · 2001 [cited by applicant]
US 6365375B1 · Dietmaier et al. · 2002 [cited by applicant]
US 6391544B1 · Salituro et al. · 2002 [cited by applicant]
US 6451569B1 · Tsien et al. · 2002 [cited by applicant]
US 6525191B1 · Ramasamy · 2003 [cited by applicant]
US 6670461B1 · Wengel et al. · 2003 [cited by applicant]
US 6720140B1 · Hartley et al. · 2004 [cited by applicant]
US 6770748B2 · Manishi et al. · 2004 [cited by applicant]
US 6794499B2 · Wengel et al. · 2004 [cited by applicant]
US 6906170B1 · Lider et al. · 2005 [cited by applicant]
US 6955807B1 · Shanafelt et al. · 2005 [cited by applicant]
US 7034133B2 · Wengel et al. · 2006 [cited by applicant]
US 7045337B2 · Schultz et al. · 2006 [cited by applicant]
US 7053207B2 · Wengel · 2006 [cited by applicant]
US 7105653B2 · Shanafelt et al. · 2006 [cited by applicant]
US 7393632B2 · Cheo et al. · 2008 [cited by applicant]
US 7399845B2 · Seth et al. · 2008 [cited by applicant]
US 7427672B2 · Imanishi et al. · 2008 [cited by applicant]
US 7625717B2 · Chin et al. · 2009 [cited by applicant]
US 7670823B1 · Hartley et al. · 2010 [cited by applicant]
US 7741457B2 · Seth et al. · 2010 [cited by applicant]
US 7744861B2 · Zhao et al. · 2010 [cited by applicant]
US 7803777B2 · DeFrees · 2010 [cited by applicant]
US 8012465B2 · Elias et al. · 2011 [cited by applicant]
US 8252743B2 · Guyon et al. · 2012 [cited by applicant]
US 8273833B2 · Bentley et al. · 2012 [cited by applicant]
US 8420792B2 · Tian et al. · 2013 [cited by applicant]
US 8501805B2 · Seth et al. · 2013 [cited by applicant]
US 8546556B2 · Seth et al. · 2013 [cited by applicant]
US 8557776B2 · Lehmann et al. · 2013 [cited by applicant]
US 8609383B2 · Young et al. · 2013 [cited by applicant]
US 9089614B2 · Lin et al. · 2015 [cited by applicant]
US 9682934B2 · Stafford et al. · 2017 [cited by applicant]
US 9732134B2 · Gavin et al. · 2017 [cited by applicant]
US 9840493B2 · Yang et al. · 2017 [cited by applicant]
US 9861705B2 · Bossard et al. · 2018 [cited by applicant]
US 9938516B2 · Zimmerman et al. · 2018 [cited by applicant]
US 9988619B2 · Zimmerman et al. · 2018 [cited by applicant]
US 10610571B2 · Ptacin et al. · 2020 [cited by applicant]
US 10851144B2 · Butz et al. · 2020 [cited by applicant]
US 10960079B2 · Bossard et al. · 2021 [cited by applicant]
US 11077195B2 · Ptacin et al. · 2021 [cited by applicant]
US 11622993B2 · Ptacin et al. · 2023 [cited by applicant]
US 11701407B2 · Ptacin et al. · 2023 [cited by applicant]
US 20020001804A1 · Mitchell et al. · 2002 [cited by applicant]
US 20020007051A1 · Cheo et al. · 2002 [cited by applicant]
US 20030083373A1 · Tsien et al. · 2003 [cited by applicant]
US 20040171570A1 · Allerson et al. · 2004 [cited by applicant]
US 20050112590A1 · Boom et al. · 2005 [cited by applicant]
US 20050118623A1 · Belousov et al. · 2005 [cited by applicant]
US 20050130923A1 · Bhat et al. · 2005 [cited by applicant]
US 20060035254A1 · Manoharan et al. · 2006 [cited by applicant]
US 20060074035A1 · Hong et al. · 2006 [cited by applicant]
US 20060084136A1 · Kudlicki et al. · 2006 [cited by applicant]
US 20060160187A1 · Denis-Mize et al. · 2006 [cited by applicant]
US 20060234205A1 · Cao et al. · 2006 [cited by applicant]
US 20060263771A1 · Hirao et al. · 2006 [cited by applicant]
US 20070287831A1 · Seth et al. · 2007 [cited by applicant]
US 20080025947A1 · Gillies et al. · 2008 [cited by applicant]
US 20080039618A1 · Allerson et al. · 2008 [cited by applicant]
US 20080300163A1 · Cho et al. · 2008 [cited by applicant]
US 20090155844A1 · Yokoyama et al. · 2009 [cited by applicant]
US 20100316595A1 · Elias et al. · 2010 [cited by applicant]
US 20100323364A1 · Sekine et al. · 2010 [cited by applicant]
US 20120022013A1 · Sinclair et al. · 2012 [cited by applicant]
US 20120077252A1 · Picataggio et al. · 2012 [cited by applicant]
US 20120244112A1 · Ast et al. · 2012 [cited by applicant]
US 20120315245A1 · Leon et al. · 2012 [cited by applicant]
US 20130333068A1 · Coffin · 2013 [cited by applicant]
US 20140046026A1 · Garcia et al. · 2014 [cited by applicant]
US 20140255345A1 · Grabstein et al. · 2014 [cited by applicant]
US 20140314864A1 · Cheng et al. · 2014 [cited by applicant]
US 20140315245A1 · Yam et al. · 2014 [cited by applicant]
US 20140328791A1 · Bossard et al. · 2014 [cited by applicant]
US 20160168187A1 · Romesberg et al. · 2016 [cited by applicant]
US 20170029829A1 · Romesberg et al. · 2017 [cited by applicant]
US 20170044229A1 · Garcia et al. · 2017 [cited by applicant]
US 20170260137A1 · Stafford et al. · 2017 [cited by applicant]
US 20170283469A1 · Thanos et al. · 2017 [cited by applicant]
US 20170313753A1 · Gavin et al. · 2017 [cited by applicant]
US 20170369871A1 · Ptacin et al. · 2017 [cited by applicant]
US 20180051065A1 · Yin · 2018 [cited by applicant]
US 20180086734A1 · Yang et al. · 2018 [cited by applicant]
US 20200181220A1 · Ptacin et al. · 2020 [cited by applicant]
US 20200188484A1 · Ptacin et al. · 2020 [cited by applicant]
US 20200231644A1 · Ptacin et al. · 2020 [cited by applicant]
US 20200299349A1 · Garcia et al. · 2020 [cited by applicant]
US 20200368293A1 · Olle · 2020 [cited by applicant]
US 20200399338A1 · Caffaro et al. · 2020 [cited by applicant]
US 20210023230A1 · Bossard et al. · 2021 [cited by applicant]
US 20210024602A1 · Sprogøe et al. · 2021 [cited by applicant]
US 20210046160A1 · Ptacin et al. · 2021 [cited by applicant]
US 20210054040A1 · Caffaro et al. · 2021 [cited by applicant]
US 20210060169A1 · Ikeda et al. · 2021 [cited by applicant]
US 20210070827A1 · Ptacin et al. · 2021 [cited by applicant]
US 20210139554A1 · Butz et al. · 2021 [cited by applicant]
US 20210196796A1 · Penaflor-Aspuria et al. · 2021 [cited by applicant]
US 20210221863A1 · Kang et al. · 2021 [cited by applicant]
US 20210299222A1 · Rodriguez et al. · 2021 [cited by applicant]
US 20210338829A1 · Caffaro et al. · 2021 [cited by applicant]
US 20220016249A1 · Ptacin et al. · 2022 [cited by applicant]
US 20220016252A1 · Abbadessa et al. · 2022 [cited by applicant]
US 20220273767A1 · Caffaro et al. · 2022 [cited by applicant]
US 20220324792A1 · Aerni et al. · 2022 [cited by applicant]
US 20230265148A1 · Hu et al. · 2023 [cited by applicant]
US 20230277627A1 · Caffaro et al. · 2023 [cited by applicant]
US 20230416327A1 · Caffaro et al. · 2023 [cited by applicant]
US 20240082359A1 · Ptacin et al. · 2024 [cited by applicant]
US 20240226309A1 · Abbadessa et al. · 2024 [cited by applicant]
US 20240287151A1 · Caffaro et al. · 2024 [cited by applicant]
CN 102665754A · 2012 [cited by applicant]
CN 104231068A · 2014 [cited by applicant]
EA 025851B1 · 2017 [cited by applicant]
EP 0154316A2 · 1985 [cited by applicant]
EP 0614907A1 · 1994 [cited by applicant]
EP 0629633A2 · 1994 [cited by applicant]
EP 0811385A2 · 1997 [cited by applicant]
EP 2130835A4 · 2010 [cited by applicant]
EP 2581450B1 · 2018 [cited by applicant]
EP 2382228B1 · 2020 [cited by applicant]
EP 3280725B1 · 2020 [cited by applicant]
EP 4011388A1 · 2022 [cited by applicant]
EP 4209503A1 · 2023 [cited by applicant]
JP S61225199A · 1986 [cited by applicant]
JP 2007510401A · 2007 [cited by applicant]
WO 9213869A1 · 1992 [cited by applicant]
WO 9414226A1 · 1994 [cited by applicant]
WO 9422890A1 · 1994 [cited by applicant]
WO 9735869A1 · 1997 [cited by applicant]
WO 9914226A2 · 1999 [cited by applicant]
WO 9921013A1 · 1999 [cited by applicant]
WO 9962923A2 · 1999 [cited by applicant]
WO 0023456A1 · 2000 [cited by applicant]
WO 0074724A2 · 2000 [cited by applicant]
WO 0105801A1 · 2001 [cited by applicant]
WO 0132887A1 · 2001 [cited by applicant]
WO 0236626A1 · 2002 [cited by applicant]
WO 02062816A1 · 2002 [cited by applicant]
WO 02068216A1 · 2002 [cited by applicant]
WO 02070533A2 · 2002 [cited by applicant]
WO 03031464A2 · 2003 [cited by applicant]
WO 03055898A1 · 2003 [cited by applicant]
WO 03070918A2 · 2003 [cited by applicant]
WO 2004007713A1 · 2004 [cited by applicant]
WO 2004060300A2 · 2004 [cited by applicant]
WO 2004106356A1 · 2004 [cited by applicant]
WO 2005007121A2 · 2005 [cited by applicant]
WO 2005021570A1 · 2005 [cited by applicant]
WO 2005026187A1 · 2005 [cited by applicant]
WO 2005092928A1 · 2005 [cited by applicant]
WO 2005045015A3 · 2005 [cited by applicant]
WO 2004099231A3 · 2006 [cited by applicant]
WO 2006049297A1 · 2006 [cited by applicant]
WO 2006081510A2 · 2006 [cited by applicant]
WO 2006082184A2 · 2006 [cited by applicant]
WO 2007015557A1 · 2007 [cited by applicant]
WO 2007066737A1 · 2007 [cited by applicant]
WO 2007090071A2 · 2007 [cited by applicant]
WO 2007093599A1 · 2007 [cited by applicant]
WO 2007085485A3 · 2007 [cited by applicant]
WO 2007134181A3 · 2008 [cited by applicant]
WO 2008067825A1 · 2008 [cited by applicant]
WO 2008101157A1 · 2008 [cited by applicant]
WO 2008106186A3 · 2008 [cited by applicant]
WO 2008150729A3 · 2008 [cited by applicant]
WO 2008154401A3 · 2008 [cited by applicant]
WO 2009006478A2 · 2009 [cited by applicant]
WO 2009123216A1 · 2009 [cited by applicant]
WO 2009155102A2 · 2009 [cited by applicant]
WO 2010023670A2 · 2010 [cited by applicant]
WO 2010085495A1 · 2010 [cited by applicant]
WO 2011043385A1 · 2011 [cited by applicant]
WO 2011053065A2 · 2011 [cited by applicant]
WO 2011139699A3 · 2011 [cited by applicant]
WO 2012065086A1 · 2012 [cited by applicant]
WO 2012146628A1 · 2012 [cited by applicant]
WO 2015021432A1 · 2015 [cited by applicant]
WO 2015038426A1 · 2015 [cited by applicant]
WO 2015157555 · 2015 [cited by applicant]
WO 2016025385A1 · 2016 [cited by applicant]
WO 2016115168A1 · 2016 [cited by applicant]
WO 2016164937A3 · 2017 [cited by applicant]
WO 2017106767A1 · 2017 [cited by applicant]
WO 2017112825A2 · 2017 [cited by applicant]
WO 2017223528A1 · 2017 [cited by applicant]
WO 2019014267A1 · 2019 [cited by applicant]
WO 2019028419A1 · 2019 [cited by applicant]
WO 2019028425A1 · 2019 [cited by applicant]
WO 2019165453A1 · 2019 [cited by applicant]
WO 2019173832A2 · 2019 [cited by applicant]
WO 2020020783A1 · 2020 [cited by applicant]
WO 2020056066A1 · 2020 [cited by applicant]
WO 2020097325A1 · 2020 [cited by applicant]
WO 2020146221A1 · 2020 [cited by applicant]
WO 2020163532A1 · 2020 [cited by applicant]
WO 2020201095A1 · 2020 [cited by applicant]
WO 2020219943A1 · 2020 [cited by applicant]
WO 2020252418A2 · 2020 [cited by applicant]
WO 2021030374A1 · 2021 [cited by applicant]
WO 2021030483A1 · 2021 [cited by applicant]
WO 2021030602A1 · 2021 [cited by applicant]
WO 2021030706A1 · 2021 [cited by applicant]
WO 2021041206A1 · 2021 [cited by applicant]
WO 2021050554A1 · 2021 [cited by applicant]
WO 2021091986A1 · 2021 [cited by applicant]
WO 2021093633A1 · 2021 [cited by applicant]
WO 2021133839A1 · 2021 [cited by applicant]
WO 2021140416A2 · 2021 [cited by applicant]
WO 2021263026A1 · 2021 [cited by applicant]
WO 2022076853A1 · 2022 [cited by applicant]
WO 2022076859A1 · 2022 [cited by applicant]
Cited By (1)
US 12,577,197